Aug 22, 2026 10:40AM
Aug 14, 2026 09:00AM
Aug 8, 2026 12:00PM
Aug 7, 2026 09:00AM
Aug 6, 2026 07:30AM
Aug 6, 2026 07:30AM
May 29, 2026 09:00AM Foremost Clean Energy and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
May 27, 2026 08:00AM
May 26, 2026 08:01AM
May 26, 2026 08:00AM
May 18, 2026 08:01AM
May 18, 2026 08:00AM
Apr 27, 2026 08:00AM
Apr 27, 2026 08:00AM BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease ahead of Topline Data in 2Q26, on May 7, 2026
Apr 14, 2026 08:00AM
Mar 12, 2026 08:00AM
Feb 27, 2026 09:00AM
Feb 23, 2026 08:00AM
Feb 21, 2026 10:45AM
Feb 12, 2026 08:00AM
Jan 8, 2026 08:03AM BioVie completes enrollment in Parkinson's disease trial
Jan 8, 2026 08:00AM
Nov 19, 2025 08:00AM
Oct 17, 2025 09:00AM
Sep 26, 2025 09:00AM
Sep 26, 2025 08:00AM
Aug 13, 2025 04:05PM
Aug 13, 2025 04:05PM BioVie Highlighted ADDRESS-LC Phase 2 Trial Design Exploring Bezisterim for the Treatment of Neurological Symptoms of Long COVID at Keystone Symposia on Long COVID and Other Post-Acute Infection Syndr
Aug 11, 2025 04:05PM
Aug 11, 2025 04:05PM
Aug 9, 2025 12:55PM
Aug 7, 2025 08:43PM
Aug 7, 2025 08:43PM
Jul 24, 2025 08:01AM
Jul 24, 2025 08:00AM BioVie Presented Data Highlighting that Patients Treated with Bezisterim Potentially Experienced an Age Deceleration Advantage Compared to Placebo on 10 Different Biological Clocks at the 2nd World Co
Jul 22, 2025 09:05AM
Jul 22, 2025 08:00AM
Jul 9, 2025 08:00AM
Jun 26, 2025 08:00AM
Jun 24, 2025 04:05PM
Jun 16, 2025 06:45PM
May 16, 2025 09:00AM BioVie and Liberty Star Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
May 15, 2025 08:00AM
May 14, 2025 07:30AM
May 7, 2025 08:00AM
May 5, 2025 08:02AM
May 5, 2025 08:00AM
Apr 25, 2025 12:45PM
Apr 16, 2025 08:00AM BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with First Patient Enrolled
Apr 8, 2025 08:56AM

330,386 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All